Published in Yonsei Med J on August 31, 2006
Reliability and validity of the Korean version of Obsessive-Compulsive Inventory-Revised in a non-clinical sample. Yonsei Med J (2008) 0.82
High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study. Behav Brain Funct (2008) 0.78
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics (1996) 6.83
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science (2003) 4.58
Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry (1995) 4.10
Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08
A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet (1998) 3.59
The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry (1988) 3.15
Problems of Obsessional Illness: (Section of Psychiatry). Proc R Soc Med (1936) 2.85
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics (1992) 2.55
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry (2000) 2.46
A family study of obsessive-compulsive disorder. Am J Psychiatry (1995) 2.24
The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J (2001) 2.05
A family study of obsessive-compulsive disorder. Arch Gen Psychiatry (2000) 2.03
Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry (1992) 1.73
Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. Arch Gen Psychiatry (1991) 1.62
Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet (1991) 1.56
Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry (2005) 1.44
Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet (2005) 1.41
Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry (2002) 1.39
Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl) (2004) 1.39
Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry (1986) 1.38
Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet (2002) 1.35
Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet (2003) 1.32
Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry (1999) 1.29
Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry (2006) 1.24
Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A (1997) 1.24
Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet (2004) 1.13
Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol (2005) 1.08
Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry (1990) 1.08
Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2005) 1.06
Psychiatric disorders in the families of patients with obsessive-compulsive disorder. Psychiatry Res (1992) 1.06
Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet (1999) 1.05
Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry (1998) 1.05
Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex. Am J Hum Genet (2000) 1.04
Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry (1990) 1.02
Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry (1999) 1.00
The current status of association studies in obsessive-compulsive disorder. Psychiatr Clin North Am (2006) 1.00
Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry (1987) 0.99
Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet (1999) 0.98
SIMILAR AND DISSIMILAR MANIFESTATIONS OF OBSESSIVE-COMPULSIVE NEUROSES IN MONOZYGOTIC TWINS. Am J Psychiatry (1965) 0.95
Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport (2004) 0.94
5HT1Dbeta Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study. Mol Psychiatry (2002) 0.93
A direct interview family study of obsessive-compulsive disorder. I. Psychol Med (2005) 0.92
Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates. Psychiatry Res (2004) 0.90
Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan. Neuropsychobiology (2004) 0.89
Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder? Am J Psychiatry (2000) 0.88
Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology (2005) 0.88
Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients. Psychopharmacology (Berl) (1998) 0.87
Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav (2004) 0.87
Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol Psychiatry (2001) 0.86
Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol (2000) 0.86
Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism. Am J Hum Genet (1992) 0.86
Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry (1992) 0.86
No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res (1998) 0.86
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J (2002) 0.85
Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands. Hum Hered (2005) 0.85
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology (1996) 0.85
Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Biol Psychiatry (1991) 0.84
Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr Genet (1998) 0.84
Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder. Int J Neuropsychopharmacol (2001) 0.83
Complex segregation analysis of obsessive-compulsive disorder in 141 families of eating disorder probands, with and without obsessive-compulsive disorder. Am J Med Genet (2000) 0.83
Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 0.83
Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies. Int Clin Psychopharmacol (1992) 0.83
Association between a catechol-o-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population. J Affect Disord (2001) 0.83
Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet (2001) 0.83
Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet (2000) 0.82
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res (1998) 0.81
Obsessive-compulsive disorder and the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. Int J Neuropsychopharmacol (2000) 0.81
Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol (2006) 0.81
Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. Eur Neuropsychopharmacol (2003) 0.81
5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry (2002) 0.81
Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. J Neural Transm (Vienna) (2004) 0.81
Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neurosci Lett (2004) 0.81
A direct interview family study of obsessive-compulsive disorder. II. Contribution of proband informant information. Psychol Med (2005) 0.80
Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depress Anxiety (2003) 0.80
A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder. Int J Neuropsychopharmacol (2004) 0.80
Genetic aspects of obsessive-compulsive disorder. Psychiatr Clin North Am (2000) 0.80
Corrigendum to "gender in obsessive-compulsive disorder: clinical and genetic findings" [Eur. Neuropsychopharmacol. 14 (2004) 105-113]. Eur Neuropsychopharmacol (2004) 0.79
DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry (1996) 0.79
Lack of association between obsessive-compulsive disorder and the dopamine D3 receptor gene: some preliminary considerations. Am J Med Genet (1994) 0.79
Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan. Eur Neuropsychopharmacol (1998) 0.78
No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene. Am J Psychiatry (2002) 0.78
T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder. Eur Psychiatry (2003) 0.77
Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. J Clin Psychiatry (1999) 0.76
5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder. Neuropsychopharmacol Hung (2006) 0.76
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial. Clin Neuropharmacol (2010) 1.16
Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging (2002) 1.13
Bilateral anterior cingulotomy for refractory obsessive-compulsive disorder: Long-term follow-up results. Stereotact Funct Neurosurg (2006) 0.96
Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology (2005) 0.88
Manganese superoxide dismutase expression correlates with chemosensitivity in human gastric cancer cell lines. Clin Cancer Res (2003) 0.88
Characteristics of social perception assessed in schizophrenia using virtual reality. Cyberpsychol Behav (2007) 0.87
Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder. Psychiatry Res (2004) 0.86
Long-term follow-up of deep brain stimulation for refractory obsessive-compulsive disorder. Psychiatry Res (2012) 0.86
A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessive-compulsive disorder. J Clin Psychiatry (2009) 0.86
Quercetin prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Med Sci (2009) 0.86
Anxiety provocation and measurement using virtual reality in patients with obsessive-compulsive disorder. Cyberpsychol Behav (2008) 0.85
An association study of catechol-O-methyltransferase and monoamine oxidase A polymorphisms and personality traits in Koreans. Neurosci Lett (2006) 0.85
Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem J (2003) 0.85
Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder. Expert Rev Neurother (2010) 0.84
Virtual reality for obsessive-compulsive disorder: past and the future. Psychiatry Investig (2009) 0.84
Sustained attention in the context of emotional processing in patients with schizophrenia. Psychiatry Res (2010) 0.83
Alexithymia in obsessive-compulsive disorder: clinical correlates and symptom dimensions. J Nerv Ment Dis (2011) 0.83
Temperament and character in subjects with obsessive-compulsive disorder. Compr Psychiatry (2009) 0.83
Serotonin transporter gene polymorphism and personality traits in a Korean population. Neuropsychobiology (2005) 0.83
Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison. Aust N Z J Psychiatry (2013) 0.83
Increased personal space of patients with schizophrenia in a virtual social environment. Psychiatry Res (2009) 0.82
Reliability and validity of the Korean version of Obsessive-Compulsive Inventory-Revised in a non-clinical sample. Yonsei Med J (2008) 0.82
Perception bias of disgust in ambiguous facial expressions in obsessive-compulsive disorder. Psychiatry Res (2010) 0.81
Development of a computer-based behavioral assessment of checking behavior in obsessive-compulsive disorder. Compr Psychiatry (2009) 0.81
Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model. Heart Vessels (2004) 0.79
Characteristics of social anxiety from virtual interpersonal interactions in patients with schizophrenia. Psychiatry (2009) 0.79
Involvement of HIF-1alpha in UVB-induced epidermal hyperplasia. Mol Cells (2009) 0.79
Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Sci (2007) 0.79
Lack of association between polymorphisms of the dopamine receptor D4 and dopamine transporter genes and personality traits in a Korean population. Yonsei Med J (2006) 0.78
Serotonin transporter gene polymorphism and migraine in the Korean population. Headache (2005) 0.78
Mechanical Stretch-Induced Protection against Myocardial Ischemia-Reperfusion Injury Involves AMP-Activated Protein Kinase. Korean J Physiol Pharmacol (2010) 0.77
Algorithm-driven treatment for bipolar disorder in Korea: Clinical feasibility, efficacy, and safety. Int J Psychiatry Clin Pract (2009) 0.77
Association between the oxytocin receptor gene polymorphism (rs53576) and bulimia nervosa. Eur Eat Disord Rev (2015) 0.77
Combined bilateral anterior cingulotomy and ventral capsule/ventral striatum deep brain stimulation for refractory obsessive-compulsive disorder with major depression: do combined procedures have a long-term benefit? Restor Neurol Neurosci (2013) 0.76
Interactive effects of background facial emotion stimulus and target salience on sustained attention performance in schizophrenia. Schizophr Res (2011) 0.76
General pharmacology of indole [2',3':3,4]pyrido[2,1-b]quinazolinium- 5,7,8,13-tetrahydro-14-methyl-5-oxo-chloride, a new anti-dementia agent. Arzneimittelforschung (2003) 0.76
Nonverbal memory dysfunction in obsessive-compulsive disorder patients with checking compulsions. Depress Anxiety (2008) 0.75
Effectiveness and tolerability of long-acting risperidone: A 9-month open-label extension of a 12-week switching study from oral antipsychotics. Int J Psychiatry Clin Pract (2009) 0.75
Preliminary Effectiveness and Sustainability of Group Aerobic Exercise Program in Patients with Schizophrenia. J Nerv Ment Dis (2016) 0.75
Comparison of checking behavior in adults with or without checking symptom of obsessive-compulsive disorder using a novel computer-based measure. Comput Methods Programs Biomed (2012) 0.75
Development and validation of a computer-based measure of symmetry and arranging behavior in obsessive-compulsive disorder: a preliminary study. Compr Psychiatry (2013) 0.75
Development of a computer based symmetry arrangement symptoms measures in obsessive-compulsive disorder. Stud Health Technol Inform (2010) 0.75
Involvement of adrenergic pathways in activation of catalase by myocardial ischemia-reperfusion. Am J Physiol Regul Integr Comp Physiol (2002) 0.75
Association of a 5-HT1Dbeta receptor gene polymorphism with obsessive-compulsive disorder in Korean male subjects. Neuropsychobiology (2009) 0.75
Provoked arrangement symptoms in obsessive-compulsive disorder using a virtual environment: A preliminary report. Comput Biol Med (2012) 0.75